Additional Cystic Fibrosis Foundation Grant

Drs. LeGrys and Moon recently (July 2016) received a second grant from the Cystic Fibrosis (CF) Foundation to extend their research into biological and analytical variation in sweat chloride concentration.  This latest grant entitled PTC-VISTA expands on the work performed in the initial VISTA grant (Variation in Sweat Testing Analysis). PTC-VISTA will examine sweat chloride variation in 110 placebo subjects enrolled in a clinical trial for an investigational drug, PTC, used to overcome premature stop codons in the CFTR gene.